FlynancialAnalyst
Posted - 4 hours ago
$BPMC $5.56B mc $XBI $IBB name holding up extremely well versus the rest of the space, just under key $100 level. 40/80 wk SMAs in firm uptrends Fully institutionally owned
JFDI
Posted - 10 hours ago
@Doozio puke low in the $XBI $IBB there ?
ponderevo
Posted - 11 hours ago
$XBI $IBB $ARKG Fun fact: the "science" is almost completely irrelevant to biotech investing. In fact, it's probably better for you as a bio investor if you have no scientific expertise whatsoever. You're welcome.
Pianomemo
Posted - 11 hours ago
$BIIB Biogen plots 30% Leqembi field force bump, omnichannel campaigns as launch enters new phase
$XBI $SPY $IBB $NDX
jfritz
Posted - 13 hours ago
$IBB $SAVA $XBI $LABU
Do_The_Opposite
Posted - 14 hours ago
$SPY $IBB $AUPH Aurinia, in terms of a B/O an high interest rate sale is not a concern as this will be 100% cash transaction IMO
RainbowTrump
Posted - 14 hours ago
$VKTX it’s obvious to big pharma $XBI $IBB that viking has the leading asset prospect for obesity. Roche literally singing its praises during its CC. They bought their own obesity asset YET still said Viking is the leader. Basically admitting they may have potentially wasted $5b on an inferior product
JoeSpringer
Posted - 14 hours ago
$SAVA Director Makes Statement Exercising Nearly $4M Warrants 10 am ET Stream Action: https://youtube.com/live/8d1XXKOkL0M $IBB $LABU $XBI
BioAmerica
Posted - 1 day ago
$IBB $XBI If Congress is really going to get involved with the short attack against $DJT, it could open a whole new look by Congress into the illegal shorting that has been going on in biotech and other small cap stocks for the past few years. Finally, we may see the SEC start to do the kind of investigations into illegal shorting. If you are long stocks, call your representative in Congress and urge them to force the SEC to start enforcing the laws that are on the books!
Max22
Posted - 1 day ago
$SRNE Got a feeling that the bs with this stock is far from over. Will take a silent seat as the biotech sector is in a downtrend $IBB My 2 cents.
Biotech_Beast
Posted - 1 day ago
$VTGN went from sub $2 to $13 last year on phase 3 results in social anxiety disorder. The company is underway in another phase 3 study in social anxiety. I take a look. $XBI $IBB https://seekingalpha.com/article/4685645-vistagen-therapeutics-pipeline-with-potential-in-anxiety-and-depression
EWavePlayer
Posted - 1 day ago
$LABU BioTech Daily. Fib level satisfied. $IBB $XBI $TECL $XLK
FlynancialAnalyst
Posted - 2 days ago
$XBI (monthly) finding support at confluence of freshly rising 10/20 mth SMAs, and May '22 low VWAP $IBB $ARKG
JoeSpringer
Posted - 2 days ago
Lane Should Love $SAVA 10:10 ET Stream Action: https://youtube.com/live/YUP1WVWB-Bs $IBB $LABU $XBI
Do_The_Opposite
Posted - 2 days ago
$SPY $IBB $XLV $NVDA $AUPH Aurinia, has been silent and very, very bearish since the strategic review ended. Should it off dropped 500 million market cap because they did not sell with profitability around the corner and 350 million in cash. I say NO.
Diefreeandsell
Posted - 3 days ago
$IBRX Trading so painstakingly similar to $iova day it got fda approval and was halted by 3:00-3:30 pm before announced news in February! last chance to buy coming up soon!🔜 $labu $tna $IBB
WallStreetBuyDip
Posted - 3 days ago
Will trade $WBA $IBB like I did for other large cap tickers. Here's the result for LARGE cap stocks. This is the result of ONLY buying when H% is low.
I have timestamps + buy fills for everything. The result speaks for itself.
Do_The_Opposite
Posted - 3 days ago
$AUPH top holders of Aurinia and change in shares recently 13F. They are smart and believe. Patient retailers $SPY $IBB $XBI
BioGem
Posted - 5 days ago
$CERS Went long, many positives: -Strong moat, minimal competition, regulatory protection, and monopoly in many countries. -Baker brothers own >10% + added in 2023. -In late 2023, directors bought stock + high CEO ownership. -Compensation tied to performance in operations and financials. -BARDA supports R&D = a ton of free value for shareholders. -The inventory buildup and shelf-life issues from 2023 have now resolved and inventories are drawn = expect YOY growth in 2024. -Cut back on operating expenses in 23 = expanding margins in 2024. Q4 financial statement was the best in its recent history. -Achieved breakeven on adj EBIDTA in Q4 and to be sustained through 24 = closer to cash breakeven. Catalysts: Q4 2024: EU RBC approval and launch. $XBI $IBB
BioGem
Posted - 5 days ago
$ANGO Went long, many positives: -Excellent turnaround story by trimming the laggard products, generating cash from divestitures, paying off debt = strong balance sheet and boosting the high growth products. -Gross margin to soon improve when transition to 3rd party mfg. -Proforma financials are excellent, and a conservative discounted cash flow valuation puts the price in the $7-8 range, and much higher if they deliver on growth after approvals of their products in various indications. EV/S is extremely undervalued below 1 for no reason. -High quality mgt with stock awards related to stock performance and net income + High stock ownership by CEO up to 7x base salary. Many catalysts coming: -Q1 24 received approval for the AlphaVac in PE, add the EU approval and launch in H2 24. -Auryon EU approval and launch in summer 2024. -Q4 24: Prostate data for Nanoknife and submission for PMA. -Strong momentum since earnings. $XBI $IBB
Top_Dog_Pro_Trader
Posted - 6 days ago
$BMRN $XBI $BBH $IBB $XLV Be interesting to see how Elliott is positioning the Company. Market has such low expectations, and is all worked up over Rox adoption. A bottom-up analysis on the pipeline and growth tells me Rox isn’t even in the shareprice. Vox is about 35% in the SP. Any positive news on Rox adoption or plans to increase adoption would be huge. Company says have patience with Rox, view the hurdles as short term.
EWavePlayer
Posted - 6 days ago
$LABU Perspective- 50% retrace while AI sits on the doorstep of the most exciting time ever for Biotech discovery and R&D. $IBB $XLK $ARKK $XPH
KimberleyAnn
Posted - 1 week ago
$ATOS $IBB 100+% incoming....
KimberleyAnn
Posted - 1 week ago
$ATOS $IBB Atossa's director bought 25,000 shares at what price? https://www.youtube.com/watch?v=BQZFdeziNsY
KimberleyAnn
Posted - 1 week ago
$ATOS $IBB Significant over all other FDA drugs Dr. Quay has.
JoeSpringer
Posted - 1 week ago
$SAVA CFO Exercises Warrants 11:45 ET Stream Action: https://youtube.com/live/X6q1DZOwOQw $IBB $LABU $XBI
Do_The_Opposite
Posted - 1 week ago
$AUPH $IBB $QQQ $SPY Squeeze em! I want 6
Do_The_Opposite
Posted - 1 week ago
$SPY $QQQ $IBB $AUPH Aurinia I'm calling all Retail to stand up and run these 11,069 put contracts at 5 strike expo tomorrow into GO FUND ME LAND.
biostock
Posted - 1 week ago
$CLNN Flying under the radar. Undervalued for the indications and quality of data. $SPY $QQQ $XBI $IBB